Differential effects of xylamine on extracellular concentrations of norepinephrine and dopamine in rat central nervous system: an in vivo electrochemical study
- PMID: 3981462
Differential effects of xylamine on extracellular concentrations of norepinephrine and dopamine in rat central nervous system: an in vivo electrochemical study
Abstract
The effects of xylamine (N-2-chloroethyl-N-ethyl-2-methylbenzylamine) on tissue content and extracellular concentration of catecholamines in the rat brain were examined after systemic administration using in vivo voltammetry and high-performance liquid chromatography-electrochemical detection. Xylamine at a dose of 12.5 mg/kg i.p. reduced the extracellular concentration of norepinephrine (NE) in the cortex, while having no effect on the extracellular concentration of dopamine in the striatum. The content of NE in the cortex was reduced by approximately 41% at a dose of 12.5 mg/kg and 62% at 25 mg/kg within a 4-hr period, whereas dopamine contents remained unaltered. Both the reduction in extracellular concentration and the depleting action of xylamine on NE content were blocked by pretreatment with desmethylimipramine. The data suggest that xylamine has a selective action on the NE system that is mediated through the neuronal uptake carrier; however, the depleting action of xylamine and its effect on extracellular NE concentration may be unrelated actions.
Similar articles
-
The actions of xylamine on central noradrenergic neurons.J Pharmacol Exp Ther. 1981 Jun;217(3):834-40. J Pharmacol Exp Ther. 1981. PMID: 7230010
-
The effects of xylamine, a nitrogen mustard on [3H]norepinephrine accumulation in rabbit aorta.J Pharmacol Exp Ther. 1980 Aug;214(2):324-7. J Pharmacol Exp Ther. 1980. PMID: 7391980
-
Inhibition of [3H]norepinephrine uptake in organ cultured rat superior cervical ganglia by xylamine.J Pharmacol Exp Ther. 1982 Jan;220(1):115-9. J Pharmacol Exp Ther. 1982. PMID: 7053407
-
Release of norepinephrine from organ-cultured superior cervical ganglia: effects of the norepinephrine uptake inhibitor xylamine.J Pharmacol Exp Ther. 1983 Jun;225(3):623-9. J Pharmacol Exp Ther. 1983. PMID: 6864523
-
The interaction of the beta-haloethyl benzylamines, xylamine, and DSP-4 with catecholaminergic neurons.Annu Rev Pharmacol Toxicol. 1990;30:387-403. doi: 10.1146/annurev.pa.30.040190.002131. Annu Rev Pharmacol Toxicol. 1990. PMID: 2188573 Review. No abstract available.